Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study
- DOI
- 10.1016/j.lanepe.2022.100438
- Published
- 2022-09
- Container
- The Lancet Regional Health - Europe
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanepe.2022.100438,
title = {Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study},
author = {Johan Sundström and Johan Bodegard and Andreas Bollmann and Marc G. Vervloet and Patrick B. Mark and Avraham Karasik and Tiago Taveira-Gomes and Manuel Botana and Kåre I. Birkeland and Marcus Thuresson and Levy Jäger and Manish M. Sood and Gijs VanPottelbergh and Navdeep Tangri},
year = {2022},
journal = {The Lancet Regional Health - Europe},
doi = {10.1016/j.lanepe.2022.100438},
url = {https://doi.org/10.1016/j.lanepe.2022.100438}
}RIS
TY - JOUR TI - Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study AU - Johan Sundström AU - Johan Bodegard AU - Andreas Bollmann AU - Marc G. Vervloet AU - Patrick B. Mark AU - Avraham Karasik AU - Tiago Taveira-Gomes AU - Manuel Botana AU - Kåre I. Birkeland AU - Marcus Thuresson AU - Levy Jäger AU - Manish M. Sood AU - Gijs VanPottelbergh AU - Navdeep Tangri PY - 2022 JO - The Lancet Regional Health - Europe DO - 10.1016/j.lanepe.2022.100438 UR - https://doi.org/10.1016/j.lanepe.2022.100438 ER -
APA
Sundström, J., Bodegard, J., Bollmann, A., Vervloet, M. G., Mark, P. B., Karasik, A., Taveira-Gomes, T., Botana, M., Birkeland, K. I., Thuresson, M., Jäger, L., Sood, M. M., VanPottelbergh, G., & Tangri, N. (2022). Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2022.100438
Source records
- crossref · retrieved 2026-09-26T03:29:32.640Z